ERFURT and BERLIN, Germany, June 17th, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX), (FSE: C4T, ISIN: CA00176G1028) announces that it has granted incentive stock options to purchase up to 371,000 common shares of the Company to certain directors, officers, employees and consultants in accordance with its stock option plan, including options to purchase up to 100,000 shares to certain directors and officers. Each option vests immediately has an exercise price of $0.50 per share and is exercisable after a hold period of four months from issuance. The options will expire on June 17th, 2021.
AMP also reminds shareholders and investors that it will hold its Annual General Meeting of Shareholders (AGM) on Monday, June 29th, 2020, beginning at 3:00 p.m. Central European Time (6:00 a.m. Pacific Standard Time) to conduct formal business follow by an online question and answer session with AMP’s management.
Questions can be submitted until Thursday, June 25th, 2020 to: email@example.com
About AMP German Cannabis Group Inc.
AMP German Cannabis Group is licensed to import European Union – Good Manufacturing Practice (EU-GMP) medical cannabis and sell to pharmaceutical distributers or pharmacists directly, the only point-of-sale for medical cannabis to German patients.
AMP has entered into a non-exclusive distribution agreement for medical cannabis with a leading distributor of pharmaceuticals products to more than 13,000 pharmacies throughout Germany for monthly shipments starting in the second half of 2020.
AMP will begin importing from the Netherlands, Canada and other countries upon its medical cannabis suppliers receiving German EU-GMP certification. For more information, please visit: www.amp-eu.com.
Mr. Alex Blodgett, CEO and Director
AMP social media links:
• Twitter: https://twitter.com/AMP_Cannabis
• LinkedIn: https://www.linkedin.com/company/ampgermancannabisgroup
• Facebook: https://www.facebook.com/AMPGCG/
• YouTube: http://ow.ly/6mZb50AaJ9y
Media Kit: https://www.amp-eu.com/media-kit
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking statements that are based on the Company’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business plans and milestones and the timing thereof. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them
publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
SOURCE AMP German Cannabis Group Inc.